Safety Tolerability and Pharmacokinetics of ALD403

NCT01579383 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

BIOLOGICAL: ALD403
BIOLOGICAL: ALD403
BIOLOGICAL: Sumatriptan

Sponsor

Alder Biopharmaceuticals, Inc.